Very Late Restenosis after Paclitaxel-Eluting Stent Implantation

  1. John Cosgrave, MD;
  2. Asif Qasim, PhD;
  3. Azeem Latib, MD;
  4. Tiziana Claudia Aranzulla, MD; and
  5. Antonio Colombo, MD
  1. From Centro Cuore Columbus and San Raffaele Scientific Institute, Milan, Italy.

    Background: Late restenosis after drug-eluting stent implantation has been described for sirolimus-eluting stents (Cypher, Johnson & Johnson, Warren, New Jersey) (1–3) but not for paclitaxel-eluting stents (Taxus, Boston Scientific, Natick, Massachusetts) (4).

    Objective: To describe a patient with a paclitaxel-eluting stent who presented with late in-stent restenosis 33 months after stent placement.

    Case Report: A 76-year-old man with a history of an inferior myocardial infarction and coronary artery bypass grafting in 1989 presented to our center in April 2004 with stable angina pectoris. In 2001, he underwent bare-metal stent implantation in the saphenous vein graft to the right coronary artery, and a covered pericardium stent was placed …

    This 100-word excerpt has been provided in the absence of an abstract.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement